Future research should focus on integrating advanced retinal models, synergistic treatment regimens, and rigorous clinical trials to harness the therapeutic potential of GLP-1RAs fully
Heydari S, Siavoshi F, Jazayeri MH, Sarrafnejad A, Saniee P
Mechanisms : Reduces TNF-alpha (key inflammatory marker) Lowers IL-6 and IL-1 (inflammatory cytokines) Modulates immune cell activity Protects tissues from inflammatory damage Applications : Joint pain (arthritis, synovitis) Inflammatory bowel conditions Autoimmune conditions (supportive therapy) General systemic inflammation Protocol : 1-2mg daily injectable, 8-12 weeks Expected results : 40-60% inflammation reduction, improved symptoms, better quality of life
Improvement in Health Markers Semaglutide has been found to improve overall health markers it can lower blood pressure, reduce cholesterol levels, and improve insulin sensitivity